Granules India Limited (BOM:532482)
India · Delayed Price · Currency is INR 861.80
+3.70 (0.43%)
At close: Aug 17, 2026
Granules India Market Cap
Granules India has a market cap or net worth of 212.63 billion as of August 17, 2026. Its market cap has increased by 90.92% in one year.
Market Cap
212.63B
Enterprise Value
218.41B
Revenue
56.32B
Ranking
n/a
PE Ratio
31.84
Stock Price
861.80
ChartMarket Cap Chart
Since February 7, 2003, Granules India's market cap has increased from 163.70M to 212.63B, an increase of 129,792.75%. That is a compound annual growth rate of 35.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 212.63B | 46.39% |
| Dec 31, 2025 | 145.25B | 1.29% |
| Dec 31, 2024 | 143.40B | 45.94% |
| Dec 29, 2023 | 98.26B | 27.40% |
| Dec 30, 2022 | 77.13B | -7.49% |
| Dec 31, 2021 | 83.37B | -4.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 575.37B |
| GlaxoSmithKline Pharmaceuticals | 455.55B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 268.01B |
| AstraZeneca Pharma India | 193.84B |
| Caplin Point Laboratories | 188.55B |
| Jubilant Pharmova | 136.92B |
| CORONA Remedies | 130.71B |